The latest price target for OPKO Health (NASDAQ:OPK) was reported by Barrington Research on November 8, 2024. The analyst firm set a price target for $2.25 expecting OPK to rise to within 12 months (a possible 41.51% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for OPKO Health (NASDAQ:OPK) was provided by Barrington Research, and OPKO Health maintained their outperform rating.

The last upgrade for OPKO Health Inc happened on June 29, 2023 when Barrington Research raised their price target to $2. Barrington Research previously had a market perform for OPKO Health Inc.

The last downgrade for OPKO Health Inc happened on January 24, 2022 when Barrington Research changed their price target from N/A to N/A for OPKO Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OPKO Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OPKO Health was filed on November 8, 2024 so you should expect the next rating to be made available sometime around November 8, 2025.

While ratings are subjective and will change, the latest OPKO Health (OPK) rating was a maintained with a price target of $2.25 to $2.25. The current price OPKO Health (OPK) is trading at is $1.59, which is out of the analyst’s predicted range.